A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis
Study sponsor: Unicycive Therapeutics, Inc · UNCY
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-05-29Actual
Enrollment · participants106Actual
Source updated2024-06-24Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.